Evidence map›Paper›PMID 21909095›Full record

ArticleNature structural & molecular biology2011

Competition between ADAR and RNAi pathways for an extensive class of RNA targets.

Diane Wu, Ayelet T Lamm, Andrew Z Fire

Open access · greenAbstract read
In one paragraph

Article in Nature structural & molecular biology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 52 papers.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

52 citing papers in PubMed, 81 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Processing ofRNA (New York, N.Y.) · 2020
    Article
  10. Review
  11. Article
  12. Article
  13. Mapping the dsRNA World.Cold Spring Harbor perspectives in biology · 2019
    Review
  14. Article
  15. Article
  16. A rADAR defense against RNAi.Genes & development · 2018
    Article
  17. Genes & development · 2018
    Article
  18. RNA Editing and Retrotransposons in Neurology.Frontiers in molecular neuroscience · 2018
    Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Diane WuDepartment of Genetics, Stanford University School of Medicine, Stanford, California, USA.
Ayelet T Lamm
Andrew Z Fire
Stanford University · US

Funding

GENE REGULATION DURING EARLY DEVELOPMENT OF C. ELEGANSR01GM037706 · NIGMS · STANFORD UNIVERSITY · PI FIRE, ANDREW Z. · 1987 to 2018
$11.0M
NIGMS NIH HHS R01 GM037706NIGMS NIH HHS R01GM37706
6 · The paper itself

Abstract

Adenosine deaminases that act on RNAs (ADARs) interact with double-stranded RNAs, deaminating adenosines to inosines. Previous studies of Caenorhabditis elegans indicated an antagonistic interaction between ADAR and RNAi machineries, with ADAR defects suppressed upon additional knockout of RNAi. This suggests a pool of common RNA substrates capable of engaging both pathways. To define and characterize such substrates, we examined small RNA and mRNA populations of ADAR mutants and identified a distinct set of loci from which RNAi-dependent short RNAs are markedly upregulated. At these same loci, we observed populations of multiply edited transcripts, supporting a specific role for ADARs in preventing access to the RNAi pathway for an extensive population of dsRNAs. Characterization of these loci revealed a substantial overlap with noncoding and intergenic regions, suggesting that the landscape of ADAR targets may extend beyond previously annotated classes of transcripts.

Indexed as

RNA InterferenceAdenosine DeaminaseDNA Transposable ElementsDown-RegulationRNARNA-Binding ProteinsRNA EditingRNA, Small InterferingADARB1 protein, humanAdenosine DeaminaseDNA Transposable ElementsRNARNA-Binding ProteinsRNA, Small Interfering

Identifiers

PMID21909095
PMCPMC3190075
OpenAlexW2003451384

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.